Dr. Nils Haep

Stacks Image 2417

Dr. Nils Haep




Stacks Image 2422
Stacks Image 2425
Stacks Image 2428
Stacks Image 2431


Dr. Nils Haep is passionate about liver research and strives to understand genetic influences in non-alcoholic steatohepatitis. He is fascinated in using tissue engineering techniques to create novel disease models. Recently, he developed and patented a transcriptional gene therapy for liver failure, with the goal of helping patients with end-stage liver disease.

Dr. Haep graduated from Heinrich-Heine-Universität Düsseldorf with a medical degree in 2015. Then, he started his training in General, Visceral, and Transplantation Surgery at Charité – Universitaetsmedizin Berlin's Department of General, Visceral, and Transplantation Surgery (Director: Prof. Pratschke). In 2020, he successfully defended his thesis (promotion), "The EphB-recpetors and their function for the podocyte". Dr. Haep completed postdoctoral training in the lab of Prof. Soto-Gutierrez at the University of Pittsburgh's liver research center between 2019 and 2022.

This website or its third-party tools use cookies, which are necessary to its functioning and required to achieve the purpose illustrated in the Disclaimer. By closing this banner, scrolling this page, clicking a link or continuing to browse otherwise, you agree to the use of cookies.